WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016095814) BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS AND PREPARATION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/095814    International Application No.:    PCT/CN2015/097489
Publication Date: 23.06.2016 International Filing Date: 15.12.2015
IPC:
C07D 403/14 (2006.01), C07D 403/10 (2006.01), A61K 31/4184 (2006.01), A61P 31/14 (2006.01)
Applicants: SUNSHINE LAKE PHARMA CO., LTD. [CN/CN]; Northern Industrial Area, Songshan Lake Dongguan, Guangdong 523000 (CN)
Inventors: ZHANG, Yingjun; (CN).
XIE, Hongming; (CN).
HU, Bailin; (CN).
LIU, Zhiqiang; (CN).
ZHANG, Jiancun; (CN).
FANG, Qinghong; (CN)
Agent: TSINGYIHUA INTELLECTUAL PROPERTY LLC; Room 301 Trade Building, Zhaolanyuan, Tsinghua University, Qinghuayuan, Haidian District Beijing 100084 (CN)
Priority Data:
201410783855.6 16.12.2014 CN
Title (EN) BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS AND PREPARATION THEREOF
(FR) COMPOSÉS CYCLIQUES PONTÉS COMME INHIBITEURS DU VIRUS DE L'HÉPATITE C ET PRÉPARATION LES COMPRENANT
Abstract: front page image
(EN)Provided herein is a compound of structure (I) or (Ia), or a stereoisomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Furthermore provided herein are pharmaceutical compositions containing the compound of structure (I) or (Ia) and use of the compounds or pharmaceutical compositions thereof in the treatment of HCV infection.
(FR)La présente invention concerne un composé de structure (I) ou (Ia), ou un stéréoisomère, un tautomère, un N-oxyde, un hydrate, un solvate, un métabolite, un sel pharmaceutiquement acceptable ou un promédicament de celui-ci. L'invention concerne également des compositions pharmaceutiques contenant le composé de structure (I) ou (Ia) et l'utilisation des composés ou des compositions pharmaceutiques les comprenant dans le traitement d'une infection à VHC.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)